Burning Mouth Syndrome Support Protocol
Primary Stack
Core supplements with strongest evidenceAntioxidant with neuroprotective properties; most studied supplement for BMS; may reduce burning symptoms
Deficiency can cause BMS-like symptoms; supplementation may help even with normal levels; supports nerve health
Supporting Stack
Additional supplements for enhanced resultsB vitamins (B1, B2, B6, B9, B12) support nerve function; deficiencies associated with oral burning
Supporting Studies (1)
Deficiency can cause taste changes and oral symptoms; may support mucosal health
Supporting Studies (1)
Iron deficiency can cause oral burning and glossitis; check levels before supplementing
Supporting Studies (1)
Supports oral mucosal health; some association between deficiency and oral conditions
Supporting Studies (1)
Anti-inflammatory; may support oral mucosal health and nerve function
Supporting Studies (1)
Desensitizes pain receptors; topical rinse may paradoxically reduce burning sensation
Supporting Studies (1)
May support oral microbiome balance; emerging research on oral health applications
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Burning Mouth Syndrome (BMS) is a chronic condition characterized by a burning, scalding, or tingling sensation in the mouth, most commonly affecting the tongue, lips, and palate. The mouth typically looks normal despite the symptoms. BMS predominantly affects postmenopausal women and can significantly impact quality of life.
BMS is classified as:
IMPORTANT: See a dentist or oral medicine specialist to rule out treatable causes such as:
MEDICAL TREATMENTS include:
* Alpha-Lipoic Acid is the most studied supplement for BMS. It has antioxidant and neuroprotective properties, and some studies show it reduces burning symptoms.
* Vitamin B12 and B-Complex - B vitamin deficiencies can cause BMS-like symptoms. Even if levels are 'normal,' supplementation may help some patients.
* Iron and Zinc should be checked, as deficiencies cause oral symptoms.
* Capsaicin rinse paradoxically reduces burning by desensitizing nerve endings.
Expected timeline: BMS is often a chronic condition. Supplements may take 2-3 months to show benefit. Some patients see spontaneous improvement over years.
Clinical Perspective
Burning Mouth Syndrome: Intraoral burning or dysesthetic sensation with normal clinical appearance. Classification: Primary (idiopathic, likely neuropathic) vs Secondary (identifiable cause). Demographics: predominantly postmenopausal women (7:1 female ratio); prevalence 0.7-4.6%. Symptoms: burning, scalding, or tingling; typically bilateral; tongue tip most common; often absent on waking, increases during day; may have altered taste, dry mouth sensation. Etiology: primary - likely small fiber neuropathy or central sensitization; secondary - nutritional deficiencies, candidiasis, xerostomia, contact allergy, medications (ACE inhibitors), diabetes, thyroid dysfunction, parafunctional habits.
CRITICAL: Exclude secondary causes before treating as primary BMS. Workup: oral exam, CBC, iron/ferritin, B12, folate, fasting glucose/HbA1c, thyroid panel, zinc. Oral culture if candidiasis suspected. Patch testing if allergy suspected. Treatment: address secondary causes; primary BMS - clonazepam topical (0.5-1mg dissolve on tongue TID), gabapentin, amitriptyline, CBT. Supplements are FIRST-LINE for secondary BMS from deficiency, and may help primary BMS.
* Alpha-Lipoic Acid (B-grade): Neuroprotection; antioxidant. Systematic review: (PMID: 26129578). Meta-analysis: (PMID: 27840029). 600-800mg daily. Most studied supplement; results mixed but favorable trend.
* Vitamin B12 (B-grade): Nerve health. Systematic review: oral symptoms (PMID: 25186231). Review: (PMID: 28660890). 1000-2000mcg daily. Sublingual may improve absorption.
* B-Complex (B-grade): Multiple B vitamins. Review: (PMID: 27450775). Daily. B1, B2, B6 especially important.
* Zinc (C-grade): Taste; mucosal. Review: (PMID: 24580542). 15-30mg daily.
* Iron (B-grade): If deficient - oral burning common with iron deficiency. Review: (PMID: 27089296). As indicated.
* Vitamin D (C-grade): Mucosal health. Review: (PMID: 28750270). 2000-4000 IU daily.
* Omega-3 Fatty Acids (C-grade): Anti-inflammatory. Review: (PMID: 27840029). 2-3g EPA+DHA daily.
* Capsaicin (B-grade): Desensitization. Clinical trial: (PMID: 24637178). Topical rinse 0.025% TID.
* Probiotics (C-grade): Oral microbiome. Review: (PMID: 29882905). Oral-specific lozenges.
Assessment targets: Symptom severity (VAS), nutritional labs, oral exam, quality of life, taste function, salivary flow (if dry mouth component).
Protocol notes: Clonazepam: dissolve on tongue rather than swallow - topical effect important; 0.25-0.5mg TID to start. Dry mouth: if present, address with saliva substitutes, pilocarpine; avoid drying medications. Candidiasis: often subclinical; trial of antifungal may be diagnostic/therapeutic. Medication review: ACE inhibitors, antiretrovirals, others can cause BMS. Dentures: remove at night; check fit; allergy to denture materials possible. Anxiety/depression: common comorbid; treating may help symptoms. CBT: effective for pain management in BMS. Parafunctional habits: tongue thrusting, bruxism may contribute. Hormonal: estrogen patches studied with some benefit; controversial. Time course: spontaneous remission occurs in some (30% within 5-7 years). Support: chronic pain condition affecting quality of life; validation important.